Market Cap 560.33B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 21.26
Forward PE 19.72
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 5,118,018
Avg Vol 7,553,768
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 83%
Beta 0.26
Analysts Strong Sell
Price Target $260.46

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
notreload_ai
notreload_ai Jun. 8 at 3:15 PM
$JNJ is acquiring Firefly Bio for $1 billion to expand its cancer pipeline. The deal brings Firefly’s Firelink platform that precisely targets hard-to-treat KRAS-driven tumors while sparing healthy tissue. https://notreload.xyz/xy/jnj-buys-firefly-bio-for-1b-to-fight-kras-cancer/
0 · Reply
BetaLaboratory
BetaLaboratory Jun. 8 at 2:08 PM
$JNJ's $1B move on Firefly Bio shows it's still willing to bet aggressively on innovation. Large pharma needs new growth engines, and biotech acquisitions remain one of the fastest ways to strengthen the pipeline and access next-generation therapies.
0 · Reply
TrendOriented
TrendOriented Jun. 8 at 1:55 PM
$OKLO Oklo just announced it is acquiring ARMEC, a precision manufacturing and engineering firm. Another step toward vertical integration in advanced nuclear and clean energy infrastructure. $JNJ Johnson & Johnson also moving, agreeing to acquire Firefly Bio for $1B, continuing its push into next-gen biotech innovation. M&A is clearly picking up again. When big players start consolidating tech and bio assets, it usually signals where the next cycle of growth is being built.
0 · Reply
focafoca99
focafoca99 Jun. 8 at 12:58 PM
$JNJ commits to acquire Firefly Bio for $1 billion, expanding its oncology pipeline with a novel degrader antibody platform. https://www.rapidticker.com/news/jnj-johnson-amp-johnson-to-acquire-a0104a
0 · Reply
HydrogenH2
HydrogenH2 Jun. 8 at 10:26 AM
$JNJ When Cramer "Pumping" this... ???
0 · Reply
TheStockTraderHub
TheStockTraderHub Jun. 8 at 5:12 AM
$JNJ forming a sweet reversal on daily, managed to close above it's .786 fib level on friday. $234 break & close on watch for a bigger move towards $240/$245+ in coming days. Support: $228
0 · Reply
TheStockTraderHub
TheStockTraderHub Jun. 8 at 5:06 AM
$JNJ forming a sweet reversal on daily, managed to close above it's .786 fib level on friday. $234 break & close on watch for a bigger move towards $240/$245+ in coming days. Support: $228
0 · Reply
Ron_Burn
Ron_Burn Jun. 7 at 1:19 PM
0 · Reply
Randomizer123
Randomizer123 Jun. 6 at 3:31 PM
$LEGN Merck will be losing exclusivity soon (2028) on cancer drug Keytruda which brings $32B revenue annually. They are in the $LEGN’s backyard (Philadelphia) similar to $JNJ
0 · Reply
LewisDaKat
LewisDaKat Jun. 6 at 3:00 PM
$JNJ Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock https://marketwirenews.com/stock/jnj/news/why-johnson-johnson-may-be-the-closest-thing-investo-8693708258825211.html?utm_source=stocktwits
0 · Reply
Latest News on JNJ
Johnson & Johnson to acquire Firefly Bio for $1B in cash

2026-06-08T12:14:56.000Z - 7 hours ago

Johnson & Johnson to acquire Firefly Bio for $1B in cash


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 8 hours ago

Johnson & Johnson to buy Firefly Bio for $1 billion


Johnson & Johnson says nipocalimab approved in China

May 21, 2026, 4:31 AM EDT - 18 days ago

Johnson & Johnson says nipocalimab approved in China


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 4 weeks ago

CVS to drop J&J's Stelara from its main formularies

CVS


J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine

May 2, 2026, 4:00 AM EDT - 5 weeks ago

J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine


Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 5 weeks ago

Why These 3 Forever Stocks Belong on Your Watchlist

WMT XOM


J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 11:03 AM EDT - 6 weeks ago

J&J sees AI halving the time to generate drug development leads


Johnson & Johnson Transcript: AGM 2026

Apr 23, 2026, 10:00 AM EDT - 6 weeks ago

Johnson & Johnson Transcript: AGM 2026


Johnson & Johnson CFO on the company's robotic surgical system

Apr 14, 2026, 10:51 AM EDT - 7 weeks ago

Johnson & Johnson CFO on the company's robotic surgical system


Johnson & Johnson Earnings Call Transcript: Q1 2026

Apr 14, 2026, 8:30 AM EDT - 7 weeks ago

Johnson & Johnson Earnings Call Transcript: Q1 2026


Johnson & Johnson Earnings release: Q1 2026

Apr 14, 2026, 8:30 AM EDT - 7 weeks ago

Johnson & Johnson Earnings release: Q1 2026


Johnson & Johnson Slides: Q1 2026

Apr 14, 2026, 8:30 AM EDT - 7 weeks ago

Johnson & Johnson Slides: Q1 2026


Johnson & Johnson Quarterly report: Q1 2026

Apr 14, 2026, 8:30 AM EDT - 7 weeks ago

Johnson & Johnson Quarterly report: Q1 2026


J&J raises guidance for 2026 on strong start to the year

Apr 14, 2026, 6:55 AM EDT - 7 weeks ago

J&J raises guidance for 2026 on strong start to the year


Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

Apr 14, 2026, 6:20 AM EDT - 7 weeks ago

Johnson & Johnson reports Q1 2026 results, raises 2026 outlook


notreload_ai
notreload_ai Jun. 8 at 3:15 PM
$JNJ is acquiring Firefly Bio for $1 billion to expand its cancer pipeline. The deal brings Firefly’s Firelink platform that precisely targets hard-to-treat KRAS-driven tumors while sparing healthy tissue. https://notreload.xyz/xy/jnj-buys-firefly-bio-for-1b-to-fight-kras-cancer/
0 · Reply
BetaLaboratory
BetaLaboratory Jun. 8 at 2:08 PM
$JNJ's $1B move on Firefly Bio shows it's still willing to bet aggressively on innovation. Large pharma needs new growth engines, and biotech acquisitions remain one of the fastest ways to strengthen the pipeline and access next-generation therapies.
0 · Reply
TrendOriented
TrendOriented Jun. 8 at 1:55 PM
$OKLO Oklo just announced it is acquiring ARMEC, a precision manufacturing and engineering firm. Another step toward vertical integration in advanced nuclear and clean energy infrastructure. $JNJ Johnson & Johnson also moving, agreeing to acquire Firefly Bio for $1B, continuing its push into next-gen biotech innovation. M&A is clearly picking up again. When big players start consolidating tech and bio assets, it usually signals where the next cycle of growth is being built.
0 · Reply
focafoca99
focafoca99 Jun. 8 at 12:58 PM
$JNJ commits to acquire Firefly Bio for $1 billion, expanding its oncology pipeline with a novel degrader antibody platform. https://www.rapidticker.com/news/jnj-johnson-amp-johnson-to-acquire-a0104a
0 · Reply
HydrogenH2
HydrogenH2 Jun. 8 at 10:26 AM
$JNJ When Cramer "Pumping" this... ???
0 · Reply
TheStockTraderHub
TheStockTraderHub Jun. 8 at 5:12 AM
$JNJ forming a sweet reversal on daily, managed to close above it's .786 fib level on friday. $234 break & close on watch for a bigger move towards $240/$245+ in coming days. Support: $228
0 · Reply
TheStockTraderHub
TheStockTraderHub Jun. 8 at 5:06 AM
$JNJ forming a sweet reversal on daily, managed to close above it's .786 fib level on friday. $234 break & close on watch for a bigger move towards $240/$245+ in coming days. Support: $228
0 · Reply
Ron_Burn
Ron_Burn Jun. 7 at 1:19 PM
0 · Reply
Randomizer123
Randomizer123 Jun. 6 at 3:31 PM
$LEGN Merck will be losing exclusivity soon (2028) on cancer drug Keytruda which brings $32B revenue annually. They are in the $LEGN’s backyard (Philadelphia) similar to $JNJ
0 · Reply
LewisDaKat
LewisDaKat Jun. 6 at 3:00 PM
$JNJ Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock https://marketwirenews.com/stock/jnj/news/why-johnson-johnson-may-be-the-closest-thing-investo-8693708258825211.html?utm_source=stocktwits
0 · Reply
Randomizer123
Randomizer123 Jun. 6 at 2:02 PM
$LEGN Legend Biotech’s CEO is effectively giving an ultimatum to $JNJ. By saying in the WSJ that he’s open to a limited partnership on in vivo CAR-T for lymphoma, he’s courting bidders. Once negotiations on the in vivo CAR-T deal reach an advanced stage, he’ll tack on the remaining 50% of the Carvykti franchise as part of the deal and sell the company. Watch out for reactions to the June 14 oral presentation. Would be surprised if a buyout didn’t happen by EOY, may be by fall 2026.
2 · Reply
clan
clan Jun. 6 at 10:41 AM
$MNKD 🚨 FDA Approved 🚨 Signs of Afrezza adoption will be forthcoming. Helping little kiddos with a life-altering medical affliction. Stay tuned. #approved #trolltrigger $SPY $JNJ $UNH
0 · Reply
ADelightfulman
ADelightfulman Jun. 6 at 6:47 AM
$KGC technical buy zone! $DRAM $SPMO $SCHD Added today. $JNJ on 🔥! Make sure you’re not Q’d up!
0 · Reply
MarketMaestro1
MarketMaestro1 Jun. 5 at 9:04 PM
While tech was selling off aggressively… defensive names quietly outperformed: $CL +4% $KO +3% $JNJ +2% This is classic risk rotation. Capital is not leaving the market. It’s rotating. The key signal is not panic—it’s positioning.
2 · Reply
OptionRunners
OptionRunners Jun. 5 at 6:57 PM
$JNJ calls are almost $6 now
0 · Reply
WunDumFuc
WunDumFuc Jun. 5 at 6:14 PM
$SPY $CAG $WMT $JNJ $PFE STAPLES are NO safety in this market: Increased production costs due to inflation as result of oil being higher and commodities higher. Staple companies have ZERO pricing power in this market with broken consumer. HE can fix 70% of issues over weekend by UNBLOCKING STRAIGHT…he is keeping it closed
0 · Reply
imjustjimmymoore
imjustjimmymoore Jun. 5 at 4:09 PM
$BTC.X $XRP.X $MRNA $JNJ Cancer Fight 101 https://www.tiktok.com/t/ZP8s6gM1f/
0 · Reply
BreakoutsHappen
BreakoutsHappen Jun. 5 at 3:37 PM
Healthcare works well $LLY $UNH $JNJ $MRK
0 · Reply
JRIGWM
JRIGWM Jun. 5 at 3:31 PM
95.51% as of 6/5/2026 Rebalancing today. Keep an eye on your HYSA interest rates. Many have gone down the past few months. However, there are some bonus deals out there exceeding national averages. Added to $SCHD and $PFFA. Next dividend $JNJ 6/10, $MSFT 6/12.
0 · Reply
JRIGWM
JRIGWM Jun. 5 at 3:30 PM
95.51% as of 6/5/2026 Rebalancing today. Keep an eye on your HYSA interest rates. Many have gone down the past few months. However, there are some bonus deals out there exceeding national averages. Added to $SCHD and $PFFA. Next dividend $JNJ 6/10, $MSFT 6/12.
0 · Reply
Suite510
Suite510 Jun. 5 at 11:00 AM
$ABT $JNJ $KVUE $SPX Talc Lawyers Ask Los Angeles Jury to Hit Johnson & Johnson With Punitive Damages: 'The Language They Speak is Money' lol 🤠🍿
1 · Reply
MaskMaker
MaskMaker Jun. 5 at 7:57 AM
0 · Reply